Indacaterol

CAS No. 312753-06-3

Indacaterol( QAB149 )

Catalog No. M14000 CAS No. 312753-06-3

Indacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 39 Get Quote
50MG 56 Get Quote
100MG 83 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Indacaterol
  • Note
    Research use only, not for human use.
  • Brief Description
    Indacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
  • Description
    Indacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
  • In Vitro
    Cell Viability Assay Cell Line:HT1080 cells (constitutively express MMP-9)Concentration:1, 2.5, 5, 10 μM Incubation Time:12 h (pretreat)Result:Significantly suppressed MMP-9 mRNA expression in the 2.5 to 10 μM range.Cell Migration Assay Cell Line:HT1080 cells (constitutively express MMP-9)Concentration:10 μM Incubation Time:6 h (pretreat for 2 h, then incubat with TNF-α for 4 h)Result:Significantly reduced cell migration of fibrosarcoma and inhibited HT1080 cell migration in the zone of wound healing.Western Blot AnalysisCell Line:HT1080 cells Concentration:1, 2.5, 5, 10 μM Incubation Time:2.5 h (pretreat for 2 h, then incubat with TNF-α for 0.5 h)Result:Suppressed TNF-α induced the phosphorylation of IκBα and IKKα/β (the upstream activators of NF-κB).Inhibited TNF-α-induced NF-κB nuclear translocation when at 5 and 10 μM.Suppressed TNF-α-induced MMP-9 enzyme activity and decreased MMP-9 protein levels in a dose-dependent manner in the 2.5 to 10 μM range.
  • In Vivo
    Animal Model:Male Wistar rats (225-250 g; myocardial infarction (MI) rat model of heart failure (HF)).Dosage:0.3 mg/kg Administration:In animal drinking water; sinle daily for 15 weeks Result:Significantly reduced both mean arterial blood pressure and heart rate.Increased both systolic and diastolic LVID where in HF, and reversed the decreased ejection fraction (%) values.Significantly reduced the infarct size, and catecholamine values to basal levels.Significantly increased β1 mRNA expression and cardiac cAMP levels in respect to HF.
  • Synonyms
    QAB149
  • Pathway
    Endocrinology/Hormones
  • Target
    Adrenergic Receptor
  • Recptor
    β-adrenoceptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    312753-06-3
  • Formula Weight
    392.49
  • Molecular Formula
    C24H28N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C1NC2=C(C([C@@H](O)CNC3CC4=C(C=C(CC)C(CC)=C4)C3)=CC=C2O)C=C1
  • Chemical Name
    5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Battram C, et al. J Pharmacol Exp Ther, 2006. 317(2): p. 762-70.
molnova catalog
related products
  • Droxidopa

    Droxidopa is a psychoactive drug and acts as a prodrug to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline).

  • Carazolol

    Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.

  • Phenylephrine hydroc...

    Phenylephrine hydrochloride is a selective α1-adrenergic receptor agonist.